Are the Newer Carbapenems of Any Value against Tuberculosis

Our aim was to assess whether newer carbapenems with a better administration profile than meropenem (ertapenem, faropenem and tebipenem) were more effective against <i>Mycobacterium tuberculosis</i> including M/XDRTB and determine if there was a synergistic/antagonistic effect with amoxi...

Full description

Saved in:
Bibliographic Details
Main Authors: Ximena Gonzalo (Author), Francis Drobniewski (Author)
Format: Book
Published: MDPI AG, 2022-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available